{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:23:16Z","timestamp":1780582996110,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI Grant-in-Aid for JSPS Fellows"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43174-8","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:46:07Z","timestamp":1773827167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intranasal delivery of bryostatin-1 using surface charge-engineered lipid nanoparticles to modulate mucosal defense for allergic rhinitis treatment"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiayue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risako","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Shinkura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"43174_CR1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12070-015-0828-5","volume":"67","author":"J Varshney","year":"2015","unstructured":"Varshney, J. & Varshney, H. Allergic rhinitis: An overview. Indian J. Otolaryngol. Head Neck Surg. 67, 143\u2013149 (2015).","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"43174_CR2","doi-asserted-by":"publisher","first-page":"874114","DOI":"10.3389\/fmed.2022.874114","volume":"9","author":"SM Nur Husna","year":"2022","unstructured":"Nur Husna, S. M., Tan, H.-T.T., Md Shukri, N., Mohd Ashari, N. S. & Wong, K. K. Allergic rhinitis: A clinical and pathophysiological overview. Front. Med. (Lausanne). 9, 874114. https:\/\/doi.org\/10.3389\/fmed.2022.874114 (2022).","journal-title":"Front. Med. (Lausanne)."},{"key":"43174_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41572-020-00227-0","volume":"6","author":"J Bousquet","year":"2020","unstructured":"Bousquet, J. et al. Allergic rhinitis. Nat. Rev. Dis. Primers. 6, 95. https:\/\/doi.org\/10.1038\/s41572-020-00227-0 (2020).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"43174_CR4","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/all.14113","volume":"75","author":"G Passalacqua","year":"2020","unstructured":"Passalacqua, G., Bagnasco, D. & Canonica, G. W. 30 years of sublingual immunotherapy. Allergy: Eur. J. Allergy Clin. Immunol. 75, 1107\u20131120 (2020).","journal-title":"Allergy: Eur. J. Allergy Clin. Immunol."},{"key":"43174_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","volume":"126","author":"M Marogna","year":"2010","unstructured":"Marogna, M., Spadolini, I., Massolo, A., Canonica, G. W. & Passalacqua, G. Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. J. Allergy Clin. Immunol. 126, 969\u2013975 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"43174_CR6","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.3390\/ijerph18073441","volume":"18","author":"B Abdullah","year":"2021","unstructured":"Abdullah, B. & Singh, S. Surgical interventions for inferior turbinate hypertrophy: A comprehensive review of current techniques and technologies. Int. J. Environ. Res. Public Health. 18, 3441. https:\/\/doi.org\/10.3390\/ijerph18073441 (2021).","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"43174_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/mi.2007.6","volume":"1","author":"AJ Macpherson","year":"2008","unstructured":"Macpherson, A. J., McCoy, K. D., Johansen, F.-E. & Brandtzaeg, P. The immune geography of IgA induction and function. Mucosal Immunol. 1, 11\u201322 (2008).","journal-title":"Mucosal Immunol."},{"key":"43174_CR8","unstructured":"Shinkura, R. & Yamamoto, Y. Bryostatin 1 for use in treating IgE mediated allergic diseases. WO 2018\/034318."},{"key":"43174_CR9","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.4049\/jimmunol.167.9.4910","volume":"167","author":"D Rabah","year":"2001","unstructured":"Rabah, D., Grant, S., Ma, C. & Conrad, D. H. Bryostatin-1 specifically inhibits in vitro IgE synthesis. J. Immunol. 167, 4910\u20134918 (2001).","journal-title":"J. Immunol."},{"key":"43174_CR10","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1038\/onc.2013.524","volume":"33","author":"R Garg","year":"2014","unstructured":"Garg, R. et al. Protein kinase c and cancer: What we know and what we do not. Oncogene 33, 5225\u20135237 (2014).","journal-title":"Oncogene"},{"key":"43174_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/10915810701464641","volume":"26","author":"G Goel","year":"2007","unstructured":"Goel, G., Makkar, H. P. S., Francis, G. & Becker, K. Phorbol esters: Structure, biological activity, and toxicity in animals. Int. J. Toxicol. 26, 279\u2013288 (2007).","journal-title":"Int. J. Toxicol."},{"key":"43174_CR12","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1021\/ja00388a092","volume":"104","author":"GR Pettit","year":"1982","unstructured":"Pettit, G. R. et al. Isolation and structure of bryostatin 1. J. Am. Chem. Soc. 104, 6846\u20136848 (1982).","journal-title":"J. Am. Chem. Soc."},{"key":"43174_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/13880209.2013.804100","volume":"52","author":"P Koll\u00e1r","year":"2014","unstructured":"Koll\u00e1r, P., Rajchard, J., Balounov\u00e1, Z. & Pazourek, J. Marine natural products: Bryostatins in preclinical and clinical studies. Pharm. Biol. 52, 237\u2013242 (2014).","journal-title":"Pharm. Biol."},{"key":"43174_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF01525985","volume":"39","author":"C Scheid","year":"1994","unstructured":"Scheid, C. et al. Immunomodulation in patients receiving intravenous bryostatin 1 in a phase I clinical study: Comparison with effects of bryostatin 1 on lymphocyte function in vitro. Cancer Immunol. Immunother. 39, 223\u2013230 (1994).","journal-title":"Cancer Immunol. Immunother."},{"key":"43174_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0192-0561(90)90110-9","volume":"12","author":"AH Esa","year":"1990","unstructured":"Esa, A. H., Boto, W. O., Adler, W. H., Stratford May, W. & Hess, A. D. Activation of T-cells by bryostatins: Induction of the IL-2 receptor gene transcription and down-modulation of surface receptors. Int. J. Immunopharmacol. 12, 481\u2013490 (1990).","journal-title":"Int. J. Immunopharmacol."},{"key":"43174_CR16","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood.V89.9.3402","volume":"89","author":"MC Bosco","year":"1997","unstructured":"Bosco, M. C. et al. The antineoplastic agent bryostatin-1 induces proinflammatory cytokine production in human monocytes: Synergy with interleukin-2 and modulation of interleukin-2R\u03b3 chain expression. Blood 89, 3402\u20133411 (1997).","journal-title":"Blood"},{"key":"43174_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0753-3322(03)00097-0","volume":"57","author":"MC Scavuzzo","year":"2003","unstructured":"Scavuzzo, M. C. et al. Cytokine secretion in nasal mucus of normal subjects and patients with allergic rhinitis. Biomed. Pharmacother. 57, 366\u2013371 (2003).","journal-title":"Biomed. Pharmacother."},{"key":"43174_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0008-8749(90)90074-2","volume":"125","author":"JN Bertolini","year":"1990","unstructured":"Bertolini, J. N. & Benson, E. M. The role of human interleukin-6 in B-cell isotype regulation and differentiation. Cell. Immunol. 125, 197\u2013209 (1990).","journal-title":"Cell. Immunol."},{"key":"43174_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1126\/science.8160012","volume":"264","author":"AJ Ramsay","year":"1994","unstructured":"Ramsay, A. J. et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264, 561\u2013563 (1994).","journal-title":"Science"},{"key":"43174_CR20","doi-asserted-by":"publisher","first-page":"e190240","DOI":"10.1172\/jci.insight.190240","volume":"10","author":"N Morita","year":"2025","unstructured":"Morita, N. et al. Regulation of selective class-switching provides long term therapeutic benefits for hay fever. JCI Insight. 10, e190240. https:\/\/doi.org\/10.1172\/jci.insight.190240 (2025).","journal-title":"JCI Insight."},{"key":"43174_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jchromb.2013.11.020","volume":"944","author":"TJ Nelson","year":"2014","unstructured":"Nelson, T. J., Sen, A., Alkon, D. L. & Sun, M.-K. Adduct formation in liquid chromatography-triple quadrupole mass spectrometric measurement of bryostatin 1. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 944, 55\u201362 (2014).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"43174_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","volume":"29","author":"FW Merkus","year":"1998","unstructured":"Merkus, F. W., Verhoef, J. C., Schipper, N. G. & Marttin, E. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv. Drug Deliv. Rev. 29, 13\u201338 (1998).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"43174_CR23","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2147\/DDDT.S447496","volume":"18","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs. Drug Des. Devel. Ther. 18, 1469\u20131495 (2024).","journal-title":"Drug Des. Devel. Ther."},{"key":"43174_CR24","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1021\/nn5002694","volume":"8","author":"DC Buehler","year":"2014","unstructured":"Buehler, D. C. et al. Bioengineered vaults: Self-assembling protein shell\u2013lipophilic core nanoparticles for drug delivery. ACS Nano 8, 7723\u20137732 (2014).","journal-title":"ACS Nano"},{"key":"43174_CR25","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1039\/D1NR05517H","volume":"14","author":"WC Wu","year":"2022","unstructured":"Wu, W. C. et al. Engineered extracellular vesicles encapsulated bryostatin-1 as therapy for neuroinflammation. Nanoscale 14, 2393\u20132410 (2022).","journal-title":"Nanoscale"},{"key":"43174_CR26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1039\/D1BM01142A","volume":"10","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Encapsulation of bryostatin-1 by targeted exosomes enhances remyelination and neuroprotection effects in the cuprizone-induced demyelinating animal model of multiple sclerosis. Biomater. Sci. 10, 714\u2013727 (2022).","journal-title":"Biomater. Sci."},{"key":"43174_CR27","doi-asserted-by":"publisher","first-page":"103070","DOI":"10.1016\/j.copbio.2024.103070","volume":"86","author":"BA Richards","year":"2024","unstructured":"Richards, B. A., Goncalves, A. G., Sullivan, M. O. & Chen, W. Engineering protein nanoparticles for drug delivery. Curr. Opin. Biotechnol. 86, 103070. https:\/\/doi.org\/10.1016\/j.copbio.2024.103070 (2024).","journal-title":"Curr. Opin. Biotechnol."},{"key":"43174_CR28","doi-asserted-by":"publisher","first-page":"101875","DOI":"10.1016\/j.cocis.2024.101875","volume":"75","author":"R Eugster","year":"2025","unstructured":"Eugster, R., Luciani, P. & Carrier, R. L. Liposomes: Bridging the gap from lab to pharmaceuticals. J. Colloid Interface Sci. 75, 101875. https:\/\/doi.org\/10.1016\/j.cocis.2024.101875 (2025).","journal-title":"J. Colloid Interface Sci."},{"key":"43174_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-bioeng-062117-121156","volume":"20","author":"TL Carlson","year":"2018","unstructured":"Carlson, T. L., Lock, J. Y. & Carrier, R. L. Engineering the mucus barrier. Annu. Rev. Biomed. Eng. 20, 197\u2013220 (2018).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"43174_CR30","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.2147\/IJN.S359118","volume":"17","author":"K Zhao","year":"2022","unstructured":"Zhao, K., Xie, Y., Lin, X. & Xu, W. The mucoadhesive nanoparticle-based delivery system in the development of mucosal vaccines. Int. J. Nanomedicine 17, 4579\u20134598 (2022).","journal-title":"Int. J. Nanomedicine"},{"key":"43174_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2174\/156720106777731019","volume":"3","author":"RM Mainardes","year":"2006","unstructured":"Mainardes, R. M. et al. Liposomes and micro\/nanoparticles as colloidal carriers for nasal drug delivery. Curr. Drug Deliv. 3, 275\u2013285 (2006).","journal-title":"Curr. Drug Deliv."},{"key":"43174_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jps.23773","volume":"103","author":"JC Kraft","year":"2014","unstructured":"Kraft, J. C., Freeling, J. P., Wang, Z. & Ho, R. J. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. J. Pharm. Sci. 103, 29\u201352 (2014).","journal-title":"J. Pharm. Sci."},{"key":"43174_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe, L. et al. Advances and challenges of liposome assisted drug delivery. Front. Pharmacol. 6, 286. https:\/\/doi.org\/10.3389\/fphar.2015.00286 (2015).","journal-title":"Front. Pharmacol."},{"key":"43174_CR34","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.colsurfb.2016.10.052","volume":"150","author":"MC Cristiano","year":"2017","unstructured":"Cristiano, M. C. et al. Anticancer activity of all- trans retinoic acid-loaded liposomes on human thyroid carcinoma cells. Colloids Surf. B Biointerfaces. 150, 408\u2013416 (2017).","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"43174_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jconrel.2014.05.036","volume":"187","author":"CM Dawidczyk","year":"2014","unstructured":"Dawidczyk, C. M. et al. State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines. J. Control. Release 187, 133\u2013144 (2014).","journal-title":"J. Control. Release"},{"key":"43174_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"A Akbarzadeh","year":"2013","unstructured":"Akbarzadeh, A. et al. Liposome: Classification, preparation, and applications. Nanoscale Res. Lett. 8, 102. https:\/\/doi.org\/10.1186\/1556-276X-8-102 (2013).","journal-title":"Nanoscale Res. Lett."},{"key":"43174_CR37","doi-asserted-by":"publisher","first-page":"21933","DOI":"10.1038\/srep21933","volume":"6","author":"YT Sato","year":"2016","unstructured":"Sato, Y. T. et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci. Rep. 6, 21933. https:\/\/doi.org\/10.1038\/srep21933 (2016).","journal-title":"Sci. Rep."},{"key":"43174_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/sj.cdd.4400473","volume":"6","author":"S Krahling","year":"1999","unstructured":"Krahling, S., Callahan, M. K., Williamson, P. & Schlegel, R. A. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ. 6, 183\u2013189 (1999).","journal-title":"Cell Death Differ."},{"key":"43174_CR39","first-page":"57","volume":"1522","author":"H Zhang","year":"2017","unstructured":"Zhang, H. Thin-film hydration followed by extrusion method for liposome preparation. Methods Mol. Biol. 1522, 57\u201363 (2017).","journal-title":"Methods Mol. Biol."},{"key":"43174_CR40","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3390\/pharmaceutics13091365","volume":"13","author":"KK Ewert","year":"2021","unstructured":"Ewert, K. K. et al. Cationic liposomes as vectors for nucleic acid and hydrophobic drug therapeutics. Pharmaceutics. 13, 1365. https:\/\/doi.org\/10.3390\/pharmaceutics13091365 (2021).","journal-title":"Pharmaceutics."},{"key":"43174_CR41","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1529\/biophysj.108.133173","volume":"95","author":"F Campelo","year":"2008","unstructured":"Campelo, F., McMahon, H. T. & Kozlov, M. M. The hydrophobic insertion mechanism of membrane curvature generation by proteins. Biophys. J. 95, 2325\u20132339 (2008).","journal-title":"Biophys. J."},{"key":"43174_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1074-7613(00)00044-3","volume":"13","author":"BB Cazac","year":"2000","unstructured":"Cazac, B. B. & Roes, J. TGF-\u03b2 receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13, 443\u2013451 (2000).","journal-title":"Immunity"},{"key":"43174_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/rr40","volume":"2","author":"JW Steinke","year":"2001","unstructured":"Steinke, J. W. & Borish, L. Th2 cytokines and asthma\u2014interleukin-4: Its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res. 2, 66. https:\/\/doi.org\/10.1186\/rr40 (2001).","journal-title":"Respir. Res."},{"key":"43174_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1096-4959(01)00440-7","volume":"130","author":"SR St\u00fcrzenbaum","year":"2001","unstructured":"St\u00fcrzenbaum, S. R. & Kille, P. Control genes in quantitative molecular biological techniques: The variability of invariance. Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 130, 281\u2013289 (2001).","journal-title":"Comp. Biochem. Physiol. B. Biochem. Mol. Biol."},{"key":"43174_CR45","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1248\/bpb.b25-00071","volume":"48","author":"H Sato","year":"2025","unstructured":"Sato, H. Development of nanoparticle-based mucosal drug delivery systems for controlling pharmacokinetic behaviors. Biol. Pharm. Bull. 48, 759\u2013768 (2025).","journal-title":"Biol. Pharm. Bull."},{"key":"43174_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1074-5521(98)90156-9","volume":"5","author":"N Platt","year":"1998","unstructured":"Platt, N. & Gordon, S. Scavenger receptors: Diverse activities and promiscuous binding of polyanionic ligands. Chem. Biol. 5, 193\u2013203 (1998).","journal-title":"Chem. Biol."},{"key":"43174_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-020-00214-z","volume":"25","author":"MB Naeini","year":"2020","unstructured":"Naeini, M. B., Bianconi, V., Pirro, M. & Sahebkar, A. The role of phosphatidylserine recognition receptors in multiple biological functions. Cell. Mol. Biol. Lett. 25, 23. https:\/\/doi.org\/10.1186\/s11658-020-00214-z (2020).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"43174_CR48","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1039\/D2NA00534D","volume":"5","author":"M Awashra","year":"2023","unstructured":"Awashra, M. & M\u0142ynarz, P. The toxicity of nanoparticles and their interaction with cells: An in vitro metabolomic perspective. Nanoscale Adv. 5, 2674\u20132723 (2023).","journal-title":"Nanoscale Adv."},{"key":"43174_CR49","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1039\/C6BM00171H","volume":"4","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Influence of cell size on cellular uptake of gold nanoparticles. Biomater. Sci. 4, 970\u2013978 (2016).","journal-title":"Biomater. Sci."},{"key":"43174_CR50","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/0952-7915(92)90064-L","volume":"4","author":"D Vercelli","year":"1992","unstructured":"Vercelli, D. & Geha, R. S. Regulation of isotype switching. Curr. Opin. Immunol. 4, 794\u2013797 (1992).","journal-title":"Curr. Opin. Immunol."},{"key":"43174_CR51","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1039\/D1CS00574J","volume":"14","author":"V Lenders","year":"2023","unstructured":"Lenders, V. et al. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport. Chem. Soc. Rev. 14, 4672\u20134724 (2023).","journal-title":"Chem. Soc. Rev."},{"key":"43174_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21769\/BioProtoc.931","volume":"3","author":"Y Sher","year":"2013","unstructured":"Sher, Y. & Hung, M. Blood AST, ALT and UREA\/BUN level analysis. Bio. Protoc. 3, 19. https:\/\/doi.org\/10.21769\/BioProtoc.931 (2013).","journal-title":"Bio. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43174-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43174-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43174-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T22:31:45Z","timestamp":1777847505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43174-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43174"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43174-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14052"}}